King® Guide to Parenteral Admixtures®
Loose-Leaf Edition

The Original Standard in Hospital Pharmacy Since 1971

Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.

King Guide loose-Leaf Edition

"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.

Features

  • Updated Quarterly Since 1971
  • Exceeds TJC Requirements
  • NABP Endorsed
  • Over 580 IV drugs with at-a-glance view of compatibility in 12 fluids
  • Over 3,100 Primary Source References
  • Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
  • Y-Site, Syringe, and other sets/container specific information.
  • Extensive TPN/TNA data.
  • Special Sections on Stability and Storage
  • Boxed Warning and Hazardous Drugs List and Identification
  • Proprietary and Generic Drug Names Included

Spring 2021

In this Supplement we added new monographs for COVID-19 VACCINE, EPTINEZUMAB-JJMR; IMIPENEM, CILASTATIN, AND RELEBACTAM; and SACITUZUMAB GOVITECAN-HZIY.

We also added new stability information to these existing drug monographs:  FOSPHENYTOIN SODIUM, METHADONE HYDROCHLORIDE, and MILRINONE LACTATE.

New compatibility information was added to these existing drug monographs: ALPROSTADIL, AMIODARONE HYDROCHLORIDE, BUMETANIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, MILRINONE LACTATE, NICARDIPINE HYDROCHLORIDE, NITROPRUSSIDE SODIUM, TOTAL PARENTERAL NUTRITION SOLUTIONS, VASOPRESSIN; and IMIPENEM, CILASTATIN, AND RELEBACTAM with nine different parenteral drugs.


Ready to Order?

Visit our Online Store

Buy Now